참고문헌
- Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2007), cancer prevalence (2007) and survival (1993-2007) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs; 2009.
- Morton RF, Jett JR, McGinnis WL, et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: a randomized, phase III trial. Ann Intern Med 1991;115:681-6. https://doi.org/10.7326/0003-4819-115-9-681
- Onn A, Vaporciyan AA, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the lung. In: Kufe DW, Bast RC, Hait WN, et al. editors. Cancer medicine. 7th ed. London: BC Decker Inc; 2006. p. 1179-224.
- Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-9.
- Curran WJ, Scott CB, Langer CJ, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410. Proc Am Soc Clin Oncol 2003;22:2499.
- Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
- Salinas FV, Winterbauer RH. Radiation pneumonitis: a mimic of infectious pneumonitis. Semin Respir Infect 1995;10:143-53.
- Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977;86:81-92. https://doi.org/10.7326/0003-4819-86-1-81
- Stover DE. Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia: J. B. Lippincott; 2005.
- Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000;48:89-94.
- Yamada M, Kudoh S, Hirata K, Nakajima T, Yoshikawa J. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 1998;34:71-5. https://doi.org/10.1016/S0959-8049(97)00377-8
- Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N, Ueoka H. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1997;39:91-8. https://doi.org/10.1016/S0360-3016(97)00297-6
- Byhardt RW, Scott C, Sause WT, et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced nonsmall- cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1998;42:469-78. https://doi.org/10.1016/S0360-3016(98)00251-X
- Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-9.
- Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-9. https://doi.org/10.1016/S0360-3016(01)01685-6
- Tsujino K, Hirota S, Endo M, et al. Predictive value of dosevolume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55:110-5. https://doi.org/10.1016/S0360-3016(02)03807-5
- Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399-407. https://doi.org/10.1016/j.ijrobp.2006.07.1337
- Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1355-63. https://doi.org/10.1016/j.ijrobp.2004.08.025
- Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 2007;67: 410-6. https://doi.org/10.1016/j.ijrobp.2006.09.030
- Bradley JD, Hope A, El Naqa I, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007;69:985-92. https://doi.org/10.1016/j.ijrobp.2007.04.077
- Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 2006;66:1281-93. https://doi.org/10.1016/j.ijrobp.2006.08.058
- Inoue A, Kunitoh H, Sekine I, Sumi M, Tokuuye K, Saijo N. Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys 2001;49:649-55. https://doi.org/10.1016/S0360-3016(00)00783-5
- Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer: a systematic review. Radiother Oncol 2004;71:127-38. https://doi.org/10.1016/j.radonc.2004.02.015
- Roach M 3rd, Gandara DR, Yuo HS, et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995;13:2606-12. https://doi.org/10.1200/JCO.1995.13.10.2606
- Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33:455-60. https://doi.org/10.1016/0360-3016(95)00009-N
- Seppenwoolde Y, De Jaeger K, Boersma LJ, Belderbos JS, Lebesque JV. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:748-58. https://doi.org/10.1016/j.ijrobp.2004.04.037
- Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005;63:672-82. https://doi.org/10.1016/j.ijrobp.2005.03.026
- Ramella S, Trodella L, Mineo TC, et al. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys 2010;76:110-5. https://doi.org/10.1016/j.ijrobp.2009.01.036
- Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003;67:275-83. https://doi.org/10.1016/S0167-8140(03)00119-1
- Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 2001;51:915-22. https://doi.org/10.1016/S0360-3016(01)01713-8
- Komaki R, Lee JS, Milas L, et al. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 2004;58:1369-77. https://doi.org/10.1016/j.ijrobp.2003.10.005
- Mehta V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 2005;63:5-24. https://doi.org/10.1016/j.ijrobp.2005.03.047
- Yuan S, Sun X, Li M, et al. A randomized study of involved-fi eld irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007;30:239-44. https://doi.org/10.1097/01.coc.0000256691.27796.24
- Beckmann GK, Kolbl O, Krieger T, Wulf J, Flentje MP. How can we further improve radiotherapy for stage-III non-small-cell lung cancer? Lung Cancer 2004;45(Suppl 2):S125-32.
- Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;58:1258-67. https://doi.org/10.1016/j.ijrobp.2003.09.086
- Kim MS. Incidence and prognostic factors of radiation pneumonitisin NSCLC treated with intensity modulated radiation therapy (IMRT). J Korean Soc Ther Radiol Oncol 2008;26:35-44. https://doi.org/10.3857/jkstro.2008.26.1.35
피인용 문헌
- Radiosensitizing effect of oleanolic acid on tumor cells through the inhibition of GSH synthesis in vitro vol.30, pp.2, 2011, https://doi.org/10.3892/or.2013.2510
- Predictive Factors for Radiation Pneumonitis in Lung Cancer Treated with Helical Tomotherapy vol.45, pp.4, 2011, https://doi.org/10.4143/crt.2013.45.4.295
- Optimal beam arrangement for pulmonary ventilation image-guided intensity-modulated radiotherapy for lung cancer vol.9, pp.None, 2011, https://doi.org/10.1186/1748-717x-9-184
- Evaluation of the Radiation Pneumonia Development Risk in Lung Cancer Cases vol.15, pp.17, 2011, https://doi.org/10.7314/apjcp.2014.15.17.7371
- Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer vol.6, pp.11, 2011, https://doi.org/10.7150/jca.12314
- Predictive SNPs for radiation-induced damage in lung cancer patients with radiotherapy: a potential strategy to individualize treatment vol.30, pp.1, 2011, https://doi.org/10.5301/jbm.5000108
- Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy vol.15, pp.None, 2015, https://doi.org/10.1186/s12885-015-1657-3
- MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy vol.7, pp.43, 2011, https://doi.org/10.18632/oncotarget.12164
- Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy vol.61, pp.16, 2011, https://doi.org/10.1088/0031-9155/61/16/6105
- Chinese Herbal Extractions for Relieving Radiation Induced Lung Injury: A Systematic Review and Meta-Analysis vol.2017, pp.None, 2011, https://doi.org/10.1155/2017/2141645
- Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis vol.13, pp.5, 2011, https://doi.org/10.1371/journal.pone.0198015
- Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy vol.19, pp.4, 2011, https://doi.org/10.1016/j.cllc.2017.12.012
- External Validation of Radiation-Induced Dyspnea Models on Esophageal Cancer Radiotherapy Patients vol.9, pp.None, 2011, https://doi.org/10.3389/fonc.2019.01411
- Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis vol.100, pp.47, 2011, https://doi.org/10.1097/md.0000000000027957
- Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury vol.12, pp.None, 2011, https://doi.org/10.3389/fimmu.2021.774807
- Radiation-Induced Lung Injury-Current Perspectives and Management vol.11, pp.3, 2011, https://doi.org/10.3390/clinpract11030056